Our Vision

We want all European patients to have access to the full therapeutic potential of phytocannabinoids. We will support continuative research on all substances of the cannabis plant and will assist to understand medical mechanisms of cannabinoids and terpenes even better in the future. We are certain that we can create multiple effective pharmaceuticals through proper application of natural cannabis – we want to be a leader in this field.

Our products that we distribute in Europe are built only to the highest pharmaceutical standards. We and our suppliers require exceptionally high standard to our quality assurance and management systems: From cultivation to packaging and distribution.

Unique and natural quality through cannabis cultivation

We develop specific cannabis genetics for different medicinal conditions and requirements. We cultivate the medical plants under highest agricultural production standards (EU-GAP) and security requirements in dedicated cannabis cultivation facilities that were built exclusively for that purpose.

Adequate intake forms through cannabis oils, extracts and flowers.

The cannabis plant has far above 400 differents substances that have been subject to little research only. Main ingredients are the phytocannabinoids like CBD and THC. The plant also contains terpenes like myrcene, limonene and beta-caryophyllene. All these substances can be of therapeutic use.

We know today that the interaction of different phytocannabinoids and terpenes can be particularly effective for certain therapeutic approaches (entourage-effect). We prefer the pharmaceutical use of the entire cannabis plant to realize its full medical potential. We refuse the chemical synthesis of singular cannabinoids for medical application.

To make the best cannabinoid medicine available for different patients and medical conditions we offer not only dried cannabis flowers to vaporize but also extracts as well as oils for the oral consumption.

Share on facebook
Share on twitter
Share on pinterest
Share on email
Share on print